Early treatment response predicted subsequent clinical response in patients with schizophrenia taking paliperidone extended-release

Psychiatry Research
En-Chi YehChih-Chiang Chiu

Abstract

This 6-week open-labeled study investigated whether early treatment response in patients receiving paliperidone extended-release (paliperidone ER) can facilitate prediction of responses at Week 6. Patients with schizophrenia or schizoaffective disorder were administered 9mg/day of paliperidone ER during the first 2 weeks, after which the dose was adjusted clinically. They were assessed on Days 0, 4, 7, 14, 28, and 42 by the Positive and Negative Syndrome Scale (PANSS). The serum concentrations of 9-hydroxyrisperidone were examined on Days 14 and 42. Among the 41 patients enrolled, 26 were classified as responders (≧50% improvement on total PANSS scores at Week 6). In the receiver-operator curves (ROC) analyses, the changes in total PANSS scores at Week 2 appeared to show more accurate predictability compared to Day 4 and Day 7. At Week 6, no significant correlation was observed between blood 9-hydroxyrisperidone concentration and the total score or changes of PANSS scores. The results suggest that early treatment response to paliperidone ER, particularly at Week 2, can serve as a suitable outcome predictor at Week 6. Using 9mg/day paliperidone ER as an initial dose for schizophrenia treatment exhibited relatively favorable tole...Continue Reading

References

Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Jong-Hoon KimYong Sik Kim
Nov 5, 2003·The American Journal of Psychiatry·Christoph U CorrellJohn M Kane
Nov 27, 2004·European Archives of Psychiatry and Clinical Neuroscience·Michael RiedelH J Möller
Nov 18, 2006·Journal of Clinical Psychopharmacology·Yue-Cune ChangChieh-Liang Huang
Mar 29, 2007·The Journal of Clinical Psychiatry·Stefan LeuchtJohn M Kane
Oct 27, 2007·The Journal of Clinical Psychiatry·Ching-Hua LinHsien-Yuan Lane
Nov 21, 2007·The British Journal of Psychiatry. Supplement·Ann M Mortimer
Oct 1, 2008·Pharmacotherapy·Jehan Marino, Joshua Caballero
Jan 13, 2009·Acta Psychiatrica Scandinavica. Supplementum·S LeuchtJ M Kane
May 15, 2009·Journal of Clinical Psychopharmacology·Lei ChenIlya A Lipkovich
Jun 30, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·M JägerM Riedel
Nov 6, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Bruce J KinonJohn M Kane
Jan 16, 2010·Journal of Clinical Psychopharmacology·Wilma KnolRob J van Marum
Apr 2, 2010·European Journal of Clinical Pharmacology·Yasmin NazirizadehChristoph Hiemke
Jun 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Rebecca Schennach-WolffMichael Riedel
Jun 24, 2010·Drugs·Claudine M Chwieduk, Gillian M Keating
Dec 15, 2010·CNS Neuroscience & Therapeutics·Magdalena Nord, Lars Farde
Jan 25, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rebecca Schennach-WolffMichael Riedel
Nov 8, 2012·Journal of Clinical Psychopharmacology·Ching-Hua LinHsien-Yuan Lane
Dec 15, 2012·Expert Review of Neurotherapeutics·Pierre S ChueGlen B Baker
Oct 8, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Stephan HeresAndreas Schreiner
Feb 26, 2015·Clinical Schizophrenia & Related Psychoses·Bruno Bertolucci OrtizRodrigo Affonseca Bressan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.